Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04336215 · ClinicalTrials.gov registry record
Rutgers COVID-19 Cohort Study
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- 829
- Enrollment target
NCT04336215 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 829 participants.
The verdict
NCT04336215 has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- 829 participants
- Enrollment target
Study Summary
Our long-term goal is to protect the health care workforce (HCW) caring for SARS-CoV-2-infected patients, their families, communities, and the general population. Our specific objective is to rapidly establish a prospective cohort to characterize the factors related to viral transmission and disease severity in a large healthcare system. We addressed this hypothesis by recruiting and longitudinally following 546 HCW and a comparison group of 283 non-HCW within a large academic health system, Rutgers Biomedical and Health Sciences (RBHS). By intensively following participants over a several year period (2020-2024) and collecting serial biospecimens (nasopharyngeal/throat swabs, blood, and saliva) and questionnaire data at multiple time points, we will uniquely characterize SARS-CoV-2 transmission and risk factors for COVID-19 among HCW and our larger academic community.
Interventions
- OTHER Non-Interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 829 participants |
| Start Date | 2020-04-07 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04336215
The ClinicalTrials.gov registry entry for NCT04336215 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 829 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional is the first listed.
NCT04336215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04336215 about?
NCT04336215 is a clinical study titled "Rutgers COVID-19 Cohort Study". Our long-term goal is to protect the health care workforce (HCW) caring for SARS-CoV-2-infected patients, their families, communities, and the general population. Our specific objective is to rapidly establish a prospective cohort to characterize the factors related to viral transmission and disease...
What is the current status of trial NCT04336215?
This trial is currently completed. The enrollment target is 829 participants. The study started on 2020-04-07. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT04336215?
The interventions under investigation include: Non-Interventional (OTHER).
Who is sponsoring clinical trial NCT04336215?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.